Please login to the form below

Not currently logged in
Email:
Password:

Duchesnay

This page shows the latest Duchesnay news and features for those working in and with pharma, biotech and healthcare.

FDA slams Kardashian West's Instagram drug promotion

FDA slams Kardashian West's Instagram drug promotion

FDA slams Kardashian West's Instagram drug promotion. Morning-sickness drug firm Duchesnay criticised over social media marketing. ... s Office of Prescription Drug Promotion to write to the drug's manufacturer Duchesnay.

Latest news

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    Duchesnay, the Canadian women’s health company, has acquired from Shionogi the rights to market Osphena, another oral treatment for dyspareunia, in North America.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics